Status:
UNKNOWN
Improvement of in Vitro Fertilization Implantation by Soluble CD146 Dose in Embryonic Culture Environment
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
in Vitro Fertilization
Eligibility:
All Genders
18-42 years
Brief Summary
The study of implantation potential of the embryo stay a priority in In Vitro Fertilization (IVF). Indeed, the selection of embryos to transfer is actually based in routine check on morphologic criter...
Eligibility Criteria
Inclusion
- Pre
- Women aged \[18;42\] years
- Men aged \> 18 years
- Trying an IVF with :
- Frozen supernumerary embryo after fresh embryo transfer realised at the end of the try or frozen embryo (frozen all), without immediately transfer possibility (ovulation hyperstimulation context/ hyperprogesteronemia for example)
- Freezing at least 2 embryos frozen separately (1/vial)
- Whatever attempt rank
- Whatever MAP (Medically Assisted Procreation) technics (IVF/ICSI)
- Potential transfer of one frozen embryo
- Volunteer couples to participate at the study, received informations about this protocol and giving both their non opposition
- \- FET realization in the selected population
Exclusion
- Refusal to participate at the study of at least one member of the couple
- Inclusion realized for a previous attempt
- IVF try with a third-party
- IVF try without embryo freezing
- Freezing only one embryo
- Non separately freezing of embryos (2/vial)
- Female patients \<18 years and \>42 years
- Male patients \<18 years
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
318 Patients enrolled
Trial Details
Trial ID
NCT03785119
Start Date
January 1 2019
End Date
January 1 2023
Last Update
December 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Biologie de la Reproduction
Marseille, France, 13005